| abstract |
The aim of the invention is to provide the highest possible bioavailability of curcumin, Boswellia and xanthohumol. To this end, the invention relates to a solubilisate, which contains curcumin in a content of less than or equal to 10% by weight, preferably less than or equal to 8% by weight, more preferably between 3 and 7% by weight. , one or more boswellic acids and / or one or more boswellic acid derivatives in a total content of less than or equal to 10% by weight, preferably less than or equal to 8% by weight, more preferably between 4.7 and 6.6% by weight, and xanthohumol in a content of less than or equal to 10% by weight, preferably less than or equal to 5% by weight, more preferably between 1 and 3% by weight, and at least one emulsifier having a hydrophilic-lipophilic balance (HLB) of less than 18, preferably between 13 and 18, in particular polysorbate 80 or polysorbate 20 or a mixture of polysorbate 20 and polysorbate 80. |